Funding supports safety studies, manufacturing and clinical planning needed before applying to test the treatment in patients ...

Drivers over the age of 70 will have to have their vision checked every three years under plans to reform driving laws ...

Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the company to lose more than 40% of their value in pre-market trading. The news is ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

People sometimes asked Tiffany Fransen if she was drunk. She wishes more people had heard of her rare disorder.

In the CRL, the Agency concluded that the NDA could not be accepted due to issues that are inherent to real-world evidence and external control studies. The Food and Drug Administration (FDA) has ...

MRC Centre for Neuromuscular Diseases, and Neurogenetics Unit, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK Conclusions: Large scale deletions and ...

Medical experts use the term “cerebellar ataxia” when referring to conditions that lead to a lack of muscle control. Dysmetria is one form of cerebellar ataxia. Dysmetria occurs due to the improper ...

PTC Therapeutics has long been trying to workshop its vatiquinone into a marketable treatment for Friedreich's ataxia (FA) after a phase 3 fail in 2023. Despite its efforts, the FDA has snubbed the ...

NEW YORK – A new long-read sequencing test from Quest Diagnostics' subsidiary Athena Diagnostics aims to help specialists more quickly detect rare ataxias caused by long repeats in the genome.

New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic causes of disease BOSTON, July 29, 2025 /PRNewswire/ -- Athena Diagnostics, the specialty neurology ...